Global Natural Killer (NK) Cell Therapeutics Market is growing with factors such as increase in usage of natural killer (NK) cells for the treatment of cancer and infectious diseases and rise in awareness about immunotherapies. Increasing investment in research and development also acts as a major factor for the growth of the market. Increase in patient population with chronic diseases and adoption of natural killer (NK) cell therapy in emerging markets has also given a boom to the global natural killer (NK) cell therapeutics market.
Advancement in natural killer (NK) cell therapies has propelled the demand of the market. However, lack of specificity and poor in-vivo survival of the cells and high cost associated with the therapies have decreased the demand of the market.
Global Natural Killer (NK) Cell Therapeutics Market Scenario
According to Data Bridge Market Research, the market for global natural killer (NK) cell therapeutics in North America has the highest market share followed by Europe and Asia-Pacific. Market leader is Merck KGaA, which accounts an estimated market share of approximately 53.18% in the global natural killer (NK) cell therapeutics market. The company has gained outstanding sale by providing advanced PDL1 targeted NK cell therapy.
- In March 2020, Merck KGaA along with Pfizer, Inc. obtained positive result from phase III trial of avelumab (a PDL1 targeted NK cell therapy) for treatment of advanced squamous cell carcinoma of the head and neck. This initiative helped the company to advance its NK cell therapy product portfolio for several types of disease treatment.
Trends Impacting the Market
Now the question is which other regions Merck KGaA, Bristol-Myers Squibb Company, Glycostem are targeting? Data Bridge Market Research has forecasted a large growth in North America natural killer (NK) cell therapeutics market and the market leaders targeting U.S. and Canada to be their next pocket revenue for 2020.
Global natural killer (NK) cell therapeutics market is becoming more competitive with companies such as Merck KGaA, Bristol-Myers Squibb Company, and Glycostem. These are the top dominating companies in natural killer (NK) cell therapeutics market and are launching more new drugs in the market. The data bridge market research new reports highlight the major growth factors and opportunities in the global natural killer (NK) cell therapeutics market.
For more analysis on the global natural killer (NK) cell therapeutics market request for a briefing with our analysts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-natural-killer-nk-cell-therapeutics-market
Natural Killer (NK) Cell Therapeutics Market Developments
- In July 2020, Glycostem collaborated with the LUMICKS for enhancement of the NK- cell mediated immunotherapy. Through this collaboration the company added z-Movi to its product development procedure which helped it to accelerate the development of NK- cell based therapy.
- In March 2018, Bristol-Myers Squibb Company signed a collaboration agreement with Nektar Therapeutics for the development of the CD122 biased agonist, a therapy that has the potential to expand the number of NK cells and enhances its cytotoxic activity against tumor cells. This agreement helped the company to accelerate the ongoing research and development activities of NK cell therapy.
Scope of the Natural Killer (NK) Cell Therapeutics Market
Global natural killer (NK) cell therapeutics market is segmented on the basis of countries into the U.S., Canada, Mexico, Germany, France, Italy, U.K., Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Luxembourg , Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific , Brazil, Argentina, Peru, Rest of South America, Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt, Rest of Middle East and Africa.
- All country based analysis of the global natural killer (NK) cell therapeutics market is further analysed based on maximum granularity into further segmentation. On the basis of therapeutics, the natural killer (NK) cell therapeutics market is segmented into NK cell therapies and NK cell directed antibodies. On the basis of approaches, the natural killer (NK) cell therapeutics market is segmented into antibody-dependent cell-mediated cytotoxicity (ADCC) and bispecific antibodies. On the basis of application, the natural killer (NK) cell therapeutics market is segmented into cancer, acute infectious diseases, immunoproliferative disorders, gastrointestinal diseases and others. On the basis of end user, the natural killer (NK) cell therapeutics market is segmented into hospitals, specialty clinics and research & academic institutes. On the basis of distribution channel, the natural killer (NK) cell therapeutics market is segmented into hospital pharmacies, direct tender and others.
To know more about the study https://www.databridgemarketresearch.com/reports/global-natural-killer-nk-cell-therapeutics-market
Key Pointers Covered in Natural Killer (NK) Cell Therapeutics Market Industry Trends and Forecast to 2027
- Market Size
- Top to Bottom Market Analysis
- Recent Developments for Market Competitors
- Recent Market Value for Different Countries
- Market value and over view of natural killer (NK) cell therapeutics market
- Company profiling of top eight players of natural killer (NK) cell therapeutics market
Key Market Competitors Covered in the Report
- Kiadis Pharma
- Cytovia Therapeutics
- Nkarta, Inc.
- Fate Therapeutics
- EMERcell
- Glycostem
- Phio Pharmaceuticals
- Innate Pharma, Inc.
- INmuneBIO
- Gamida Cell
- Bellicum Phamaceuticals, Inc.
- Acepodia Inc.
- Affimed GmbH
- multimmune GmbH
- Bristol-Myers Squibb Company
- Kleo Pharmaceuticals
- iCell Gene Therapeutics
- Takeda Pharmaceutical Company Limited
- Regeneron Pharmaceuticals Inc.
- NantKwest
- Merck KGaA
Above are the key players covered in the report, to know about more and exhaustive list of natural killer (NK) cell therapeutics companies’, contact us https://www.databridgemarketresearch.com/toc/?dbmr=global-natural-killer-nk-cell-therapeutics-market
Research Methodology: Natural Killer (NK) Cell Therapeutics Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Primary Respondents
- Demand Side: Manufacturer, Healthcare Industry, Immunologists, Oncologists, Scientists, Research Laboratories
- Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.
Related Reports
Global Bispecific Antibody Market - Industry Trends and Forecast to 2026
|
Global Natural Killer (NK) Cell Therapeutics Market - Industry Trends and Forecast to 2026
Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/
|
